Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Darell D. Bigner, MD, PhD, Duke University Medical Center Identifier:
First received: November 1, 1999
Last updated: April 22, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: November 2003 (Final data collection date for primary outcome measure)